Suppr超能文献

药物诱导的肾上腺肥大提供了肾上腺皮质系统重新设定的证据。

Drug-induced adrenal hypertrophy provides evidence for reset in the adrenocortical system.

作者信息

Akana S F, Shinsako J, Dallman M F

出版信息

Endocrinology. 1983 Dec;113(6):2232-7. doi: 10.1210/endo-113-6-2232.

Abstract

These studies were performed to determine how bilateral adrenal hypertrophy persists despite normal resting ACTH levels in male rats for weeks after a 3-day course of treatment with cyanoketone (CK). This drug blocks corticosterone synthesis by binding to the enzyme 3 beta-ol-dehydrogenase-delta 5, delta 4-isomerase (EC 1.1.1.51). Although plasma ACTH levels were significantly elevated at all times during the course of treatment with CK, ACTH and corticosterone levels of CK-treated rats were normal thereafter compared to those in control rats killed in the morning. Despite these normal ACTH levels, adrenal weight remained elevated (by 100%) for at least 14 days. We determined that increased ACTH secretion was required to initiate and maintain the adrenal growth response to CK. Rats pretreated with hypophysectomy or dexamethasone (1 mg/kg) did not respond with increases in adrenal weight after CK treatment. Sustained elevations in ACTH during CK treatment were required for increased adrenal weight, because rats treated with dexamethasone 3 h after CK injection did not have enlarged adrenals at 24 h. Increased adrenal weight was not sustained after removal of supranormal levels of ACTH achieved by infusion, suggesting that after adrenal hypertrophy is achieved by ACTH, elevated ACTH levels are also required to maintain adrenal enlargement. Finally, ACTH and corticosterone levels were measured in the evening (at the peak of the diurnal rhythm in the adrenocortical system of rats) in CK-treated rats. Evening ACTH levels were significantly elevated in CK-treated rats compared to those in controls 7, 10, and 14 days after the onset of 3 days of treatment with CK; however, corticosterone levels were normal. The effects of CK on the adrenocortical system were exerted via the adrenal, since adrenalectomy normalized the amplitude of the diurnal rhythm of ACTH in CK-treated rats compared to that in adrenalectomized controls. We conclude 1) that adrenal hypertrophy after CK is maintained by increased ACTH secretion which occurs daily in the evening; and 2) that the results provide evidence for a daily reset of the corticosteroid feedback sensor in the adrenocortical system. This conclusion arises from the findings that there is a normal rhythm in corticosterone levels in CK-treated rats and that morning ACTH levels are normal although evening ACTH levels are significantly elevated.

摘要

进行这些研究是为了确定在给予雄性大鼠为期3天的氰基酮(CK)治疗后数周,尽管其静息促肾上腺皮质激素(ACTH)水平正常,但双侧肾上腺肥大是如何持续存在的。这种药物通过与3β-醇脱氢酶-δ5,δ4-异构酶(EC 1.1.1.51)结合来阻断皮质酮的合成。尽管在CK治疗过程中血浆ACTH水平在所有时间均显著升高,但与早晨处死的对照大鼠相比,CK治疗大鼠的ACTH和皮质酮水平此后恢复正常。尽管ACTH水平正常,但肾上腺重量至少在14天内仍维持升高(达100%)。我们确定,需要增加ACTH分泌来启动并维持肾上腺对CK的生长反应。预先接受垂体切除或地塞米松(1mg/kg)处理的大鼠在接受CK治疗后肾上腺重量未增加。CK治疗期间ACTH持续升高是肾上腺重量增加所必需的,因为在CK注射后3小时给予地塞米松治疗的大鼠在24小时时肾上腺未增大。通过输注使ACTH达到超常水平后去除该超常水平,肾上腺重量增加不能持续,这表明在ACTH导致肾上腺肥大后,也需要升高的ACTH水平来维持肾上腺增大。最后,在晚上(大鼠肾上腺皮质系统昼夜节律的峰值时)测量CK治疗大鼠的ACTH和皮质酮水平。与对照相比,在给予CK 3天治疗开始后的7、10和14天,CK治疗大鼠晚上的ACTH水平显著升高;然而,皮质酮水平正常。CK对肾上腺皮质系统的作用是通过肾上腺发挥的,因为与肾上腺切除的对照相比,肾上腺切除使CK治疗大鼠ACTH昼夜节律的幅度恢复正常。我们得出结论:1)CK治疗后的肾上腺肥大通过每晚发生的ACTH分泌增加得以维持;2)这些结果为肾上腺皮质系统中皮质类固醇反馈传感器的每日重置提供了证据。这一结论源于以下发现:CK治疗大鼠的皮质酮水平存在正常节律,且早晨ACTH水平正常,尽管晚上ACTH水平显著升高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验